DE112015001085T5 - Antibodies, uses and procedures - Google Patents
Vasculitis of a muscle arteriole with fibrinoid necrosis... | Download Scientific Diagram
DE112016001013T5 - ANTIBODIES, USES AND METHODS - Google Patents
Pulmonale granulomatöse Erkrankungen und pulmonale Manifestationen systemischer Granulomatosen | SpringerLink
Genetische Risikofaktoren von Vaskulitiden | SpringerLink
DE112016001013T5 - ANTIBODIES, USES AND METHODS - Google Patents
irheuma
sensitivity, specificity, positive predictive value, and negative... | Download Scientific Diagram
Rheumatologie 5 Flashcards | Quizlet
Wegener-Granulomatose und mikroskopische Polyangiitis | SpringerLink
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
ANCA–assoziierte granulomatöse Polyangiitis – gestern Erkennung, heute Behandlung, morgen Heilung | MedMedia
irheuma
Wegener-Granulomatose und mikroskopische Polyangiitis | SpringerLink
Vaskulitiden und eosinophile Lungenerkrankungen | SpringerLink
Baseline characteristics at diagnosis and induction treatment of 174... | Download Table
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
PHARMACEUTICALLY ACTIVE 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF PROTEIN KINASES - Patent 1678147
PDF) Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse
Granulomatose mit Polyangiitis - DocCheck Flexikon
a) Median GFR during follow-up in diagnostic groups GPA and MPA. For... | Download Scientific Diagram
Vaskulitis | SpringerLink
ANCA–assoziierte granulomatöse Polyangiitis – gestern Erkennung, heute Behandlung, morgen Heilung | MedMedia
Häufiges ist häufig Flashcards | Quizlet
Wegener-Granulomatose und mikroskopische Polyangiitis | SpringerLink
